HLA-DPA1 and HLA-DPB1 expression is downregulated in pediatric asthma with high diagnostic value
This guideline presents a multi-level integrated transcriptomic analysis focused on pediatric asthma patients. The scope covers molecular mechanisms including HLA-DPA1 and HLA-DPB1 expression, antigen presentation, and metabolic dysfunction within the disease context.
The analysis indicates that HLA-DPA1 and HLA-DPB1 expression is significantly downregulated in pediatric asthma samples. Diagnostic value is described as high. Additionally, antigen presentation is attenuated while metabolic dysfunction is enhanced. In IL-13-treated bronchial epithelial cells and patient samples, reduced mRNA and protein expression of HLA-DPA1 and HLA-DPB1 is observed.
Macrophage subclustering reveals that HLA-DPA1 and HLA-DPB1 are enriched in the Macro2 subset, which is characterized by metabolic and stress-related functions. Pseudotime trajectory analysis shows a shift from immune-activated toward metabolically stressed states. Cell-cell communication identifies epithelial cells as primary signal senders, macrophages and dendritic cells as central receivers, and the MIF signaling axis as a key intercellular bridge.
The authors note that direct functional validation is required to establish causality. This guideline lays a foundation for potential molecular targets for future precision therapeutic strategies. No adverse events or safety data are reported.